Author response for 'Efficacy and Safety of Monotherapy with Enavogliflozin in Korean Patients with Type 2 Diabetes Mellitus: Results of a 12‐week, multi‐center, randomized, double‐blind, placebo‐controlled, phase 2 trial'
العنوان: | Author response for 'Efficacy and Safety of Monotherapy with Enavogliflozin in Korean Patients with Type 2 Diabetes Mellitus: Results of a 12‐week, multi‐center, randomized, double‐blind, placebo‐controlled, phase 2 trial' |
---|---|
المؤلفون: | null Ye Seul Yang, null Kyung Wan Min, null Seok‐O Park, null Kyung‐Soo Kim, null Jae Myung Yu, null Eun‐Gyoung Hong, null Sung Rae Cho, null Kyu Chang Won, null Yong Hyun Kim, null Seungjoon Oh, null Sung Hee Choi, null Gwanpyo Koh, null Wan Huh, null Su Young Kim, null Kyong Soo Park |
بيانات النشر: | Wiley, 2023. |
سنة النشر: | 2023 |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af6fd139dab21b37fe4e5704f790f811 https://doi.org/10.1111/dom.15080/v3/response1 |
رقم الأكسشن: | edsair.doi.dedup.....af6fd139dab21b37fe4e5704f790f811 |
قاعدة البيانات: | OpenAIRE |
الوصف غير متاح. |